A closer look at the technologies used by Xbrane Biopharma
Xbrane Biopharma
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheeles Väg 5, Solna, Stockholm, 171 65...Phone Number
+46 738535802Website
www.xbrane.comRevenue
$28.1 MillionStock Symbol
XBRANEIndustry
About Xbrane Biopharma
Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. The company offers Ximluci, a ranibizumab biosimilar used for the treatment of various eye diseases, including wet form of age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and visual impairment due to cordial neovascularization in adults; and XB003, a biosimilar candidate to certolizumab pegol for the treatment of rheumatoid arthritis, psoriasis, Crohn's disease and axial spondylitis.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Xbrane Biopharma Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xbrane Biopharma
Sign Up For FreeTo access detailed company insights
Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. The company offers Ximluci, a ranibizumab biosimilar used for the treatment of various eye diseases, including wet form of age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and... Read More
